Go Pro

Diploma (DPLM) Competitors

Diploma logo
GBX 7,320 -10.00 (-0.14%)
As of 07/31/2026 12:33 PM Eastern

DPLM vs. IGG, DPH, HWDN, CTY, and GNS

Should you buy Diploma stock or one of its competitors? MarketBeat compares Diploma with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Diploma include IG Group (IGG), Dechra Pharmaceuticals (DPH), Howden Joinery Group (HWDN), City of London (CTY), and Genus (GNS).

How does Diploma compare to IG Group?

IG Group (LON:IGG) and Diploma (LON:DPLM) are related mid-cap companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, dividends, risk, profitability, earnings and media sentiment.

IG Group has a net margin of 43.07% compared to Diploma's net margin of 9.42%. IG Group's return on equity of 26.63% beat Diploma's return on equity.

Company Net Margins Return on Equity Return on Assets
IG Group43.07% 26.63% 10.37%
Diploma 9.42%18.55%8.32%

IG Group has higher earnings, but lower revenue than Diploma. IG Group is trading at a lower price-to-earnings ratio than Diploma, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
IG Group£949.10M5.08£533.35M£105.1013.89
Diploma£1.65B5.96£115.40M£140.8051.99

74.0% of IG Group shares are owned by institutional investors. Comparatively, 67.3% of Diploma shares are owned by institutional investors. 1.2% of IG Group shares are owned by company insiders. Comparatively, 1.1% of Diploma shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

IG Group has a beta of 0.531, indicating that its stock price is 47% less volatile than the broader market. Comparatively, Diploma has a beta of 0.918, indicating that its stock price is 8% less volatile than the broader market.

IG Group pays an annual dividend of GBX 46.50 per share and has a dividend yield of 3.2%. Diploma pays an annual dividend of GBX 62.30 per share and has a dividend yield of 0.9%. IG Group pays out 44.2% of its earnings in the form of a dividend. Diploma pays out 44.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. IG Group is clearly the better dividend stock, given its higher yield and lower payout ratio.

IG Group currently has a consensus price target of GBX 1,338, suggesting a potential downside of 8.36%. Diploma has a consensus price target of GBX 7,044.29, suggesting a potential downside of 3.77%. Given Diploma's higher possible upside, analysts plainly believe Diploma is more favorable than IG Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
IG Group
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
3.00
Diploma
0 Sell rating(s)
3 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.63

In the previous week, IG Group had 11 more articles in the media than Diploma. MarketBeat recorded 13 mentions for IG Group and 2 mentions for Diploma. Diploma's average media sentiment score of 0.67 beat IG Group's score of 0.41 indicating that Diploma is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
IG Group
3 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Diploma
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

IG Group beats Diploma on 10 of the 17 factors compared between the two stocks.

How does Diploma compare to Dechra Pharmaceuticals?

Diploma (LON:DPLM) and Dechra Pharmaceuticals (LON:DPH) are related mid-cap companies, but which is the superior business? We will compare the two companies based on the strength of their risk, valuation, media sentiment, analyst recommendations, dividends, earnings, institutional ownership and profitability.

Diploma has a net margin of 9.42% compared to Dechra Pharmaceuticals' net margin of -3.66%. Diploma's return on equity of 18.55% beat Dechra Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
Diploma9.42% 18.55% 8.32%
Dechra Pharmaceuticals -3.66%-3.92%0.75%

Diploma pays an annual dividend of GBX 62.30 per share and has a dividend yield of 0.9%. Dechra Pharmaceuticals pays an annual dividend of GBX 45 per share. Diploma pays out 44.2% of its earnings in the form of a dividend. Dechra Pharmaceuticals pays out -18,000.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Diploma presently has a consensus price target of GBX 7,044.29, indicating a potential downside of 3.77%. Given Dechra Pharmaceuticals' higher probable upside, analysts clearly believe Dechra Pharmaceuticals is more favorable than Diploma.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Diploma
0 Sell rating(s)
3 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.63
Dechra Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

67.3% of Diploma shares are owned by institutional investors. Comparatively, 105.5% of Dechra Pharmaceuticals shares are owned by institutional investors. 1.1% of Diploma shares are owned by insiders. Comparatively, 9.3% of Dechra Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Diploma has a beta of 0.918, meaning that its share price is 8% less volatile than the broader market. Comparatively, Dechra Pharmaceuticals has a beta of 0.78, meaning that its share price is 22% less volatile than the broader market.

Diploma has higher revenue and earnings than Dechra Pharmaceuticals. Dechra Pharmaceuticals is trading at a lower price-to-earnings ratio than Diploma, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Diploma£1.65B5.96£115.40M£140.8051.99
Dechra Pharmaceuticals£761.50M0.00-£27.90M-£0.25N/A

In the previous week, Diploma had 2 more articles in the media than Dechra Pharmaceuticals. MarketBeat recorded 2 mentions for Diploma and 0 mentions for Dechra Pharmaceuticals. Diploma's average media sentiment score of 0.67 beat Dechra Pharmaceuticals' score of 0.00 indicating that Diploma is being referred to more favorably in the media.

Company Overall Sentiment
Diploma Positive
Dechra Pharmaceuticals Neutral

Summary

Diploma beats Dechra Pharmaceuticals on 13 of the 17 factors compared between the two stocks.

How does Diploma compare to Howden Joinery Group?

Howden Joinery Group (LON:HWDN) and Diploma (LON:DPLM) are related mid-cap companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, profitability, media sentiment, risk, valuation and earnings.

In the previous week, Howden Joinery Group had 1 more articles in the media than Diploma. MarketBeat recorded 3 mentions for Howden Joinery Group and 2 mentions for Diploma. Diploma's average media sentiment score of 0.67 beat Howden Joinery Group's score of -0.58 indicating that Diploma is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Howden Joinery Group
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Negative
Diploma
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Howden Joinery Group pays an annual dividend of GBX 21.30 per share and has a dividend yield of 2.7%. Diploma pays an annual dividend of GBX 62.30 per share and has a dividend yield of 0.9%. Howden Joinery Group pays out 43.5% of its earnings in the form of a dividend. Diploma pays out 44.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Howden Joinery Group is clearly the better dividend stock, given its higher yield and lower payout ratio.

Howden Joinery Group has a net margin of 10.86% compared to Diploma's net margin of 9.42%. Howden Joinery Group's return on equity of 22.80% beat Diploma's return on equity.

Company Net Margins Return on Equity Return on Assets
Howden Joinery Group10.86% 22.80% 10.70%
Diploma 9.42%18.55%8.32%

67.4% of Howden Joinery Group shares are held by institutional investors. Comparatively, 67.3% of Diploma shares are held by institutional investors. 1.0% of Howden Joinery Group shares are held by company insiders. Comparatively, 1.1% of Diploma shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Howden Joinery Group has higher revenue and earnings than Diploma. Howden Joinery Group is trading at a lower price-to-earnings ratio than Diploma, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Howden Joinery Group£2.45B1.77£253.42M£49.0016.09
Diploma£1.65B5.96£115.40M£140.8051.99

Howden Joinery Group has a beta of 1.302, meaning that its stock price is 30% more volatile than the broader market. Comparatively, Diploma has a beta of 0.918, meaning that its stock price is 8% less volatile than the broader market.

Howden Joinery Group currently has a consensus price target of GBX 1,009.40, suggesting a potential upside of 28.02%. Diploma has a consensus price target of GBX 7,044.29, suggesting a potential downside of 3.77%. Given Howden Joinery Group's higher probable upside, equities analysts clearly believe Howden Joinery Group is more favorable than Diploma.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Howden Joinery Group
0 Sell rating(s)
3 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.40
Diploma
0 Sell rating(s)
3 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.63

Summary

Howden Joinery Group beats Diploma on 11 of the 18 factors compared between the two stocks.

How does Diploma compare to City of London?

Diploma (LON:DPLM) and City of London (LON:CTY) are related mid-cap companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, dividends, profitability, earnings, risk, analyst recommendations, media sentiment and institutional ownership.

Diploma pays an annual dividend of GBX 62.30 per share and has a dividend yield of 0.9%. City of London pays an annual dividend of GBX 21.45 per share and has a dividend yield of 3.6%. Diploma pays out 44.2% of its earnings in the form of a dividend. City of London pays out 18.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. City of London is clearly the better dividend stock, given its higher yield and lower payout ratio.

City of London has a net margin of 97.40% compared to Diploma's net margin of 9.42%. City of London's return on equity of 22.92% beat Diploma's return on equity.

Company Net Margins Return on Equity Return on Assets
Diploma9.42% 18.55% 8.32%
City of London 97.40%22.92%4.00%

67.3% of Diploma shares are owned by institutional investors. Comparatively, 8.7% of City of London shares are owned by institutional investors. 1.1% of Diploma shares are owned by company insiders. Comparatively, 0.1% of City of London shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

City of London has lower revenue, but higher earnings than Diploma. City of London is trading at a lower price-to-earnings ratio than Diploma, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Diploma£1.65B5.96£115.40M£140.8051.99
City of London£568.96M5.37£294.08M£113.995.20

In the previous week, Diploma had 1 more articles in the media than City of London. MarketBeat recorded 2 mentions for Diploma and 1 mentions for City of London. Diploma's average media sentiment score of 0.67 beat City of London's score of 0.64 indicating that Diploma is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Diploma
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
City of London
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Diploma currently has a consensus target price of GBX 7,044.29, suggesting a potential downside of 3.77%. Given Diploma's stronger consensus rating and higher probable upside, equities research analysts clearly believe Diploma is more favorable than City of London.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Diploma
0 Sell rating(s)
3 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.63
City of London
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Diploma has a beta of 0.918, meaning that its share price is 8% less volatile than the broader market. Comparatively, City of London has a beta of 0.502, meaning that its share price is 50% less volatile than the broader market.

Summary

Diploma beats City of London on 13 of the 18 factors compared between the two stocks.

How does Diploma compare to Genus?

Diploma (LON:DPLM) and Genus (LON:GNS) are related companies, but which is the better stock? We will compare the two companies based on the strength of their risk, valuation, dividends, analyst recommendations, profitability, media sentiment, institutional ownership and earnings.

In the previous week, Diploma had 2 more articles in the media than Genus. MarketBeat recorded 2 mentions for Diploma and 0 mentions for Genus. Diploma's average media sentiment score of 0.67 beat Genus' score of 0.00 indicating that Diploma is being referred to more favorably in the media.

Company Overall Sentiment
Diploma Positive
Genus Neutral

Diploma has higher revenue and earnings than Genus. Genus is trading at a lower price-to-earnings ratio than Diploma, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Diploma£1.65B5.96£115.40M£140.8051.99
Genus£672M2.17£7.87M£71.0030.90

67.3% of Diploma shares are owned by institutional investors. Comparatively, 52.2% of Genus shares are owned by institutional investors. 1.1% of Diploma shares are owned by company insiders. Comparatively, 0.7% of Genus shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Diploma currently has a consensus price target of GBX 7,044.29, indicating a potential downside of 3.77%. Genus has a consensus price target of GBX 3,216.67, indicating a potential upside of 46.61%. Given Genus' stronger consensus rating and higher possible upside, analysts clearly believe Genus is more favorable than Diploma.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Diploma
0 Sell rating(s)
3 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.63
Genus
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

Diploma has a net margin of 9.42% compared to Genus' net margin of 7.07%. Diploma's return on equity of 18.55% beat Genus' return on equity.

Company Net Margins Return on Equity Return on Assets
Diploma9.42% 18.55% 8.32%
Genus 7.07%9.70%3.31%

Diploma has a beta of 0.918, suggesting that its stock price is 8% less volatile than the broader market. Comparatively, Genus has a beta of 0.901, suggesting that its stock price is 10% less volatile than the broader market.

Diploma pays an annual dividend of GBX 62.30 per share and has a dividend yield of 0.9%. Genus pays an annual dividend of GBX 32 per share and has a dividend yield of 1.5%. Diploma pays out 44.2% of its earnings in the form of a dividend. Genus pays out 45.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Summary

Diploma beats Genus on 15 of the 18 factors compared between the two stocks.

Get Diploma News Delivered to You Automatically

Sign up to receive the latest news and ratings for DPLM and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DPLM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DPLM vs. The Competition

MetricDiplomaTrading Companies & Distributors IndustryIndustrials SectorLON Exchange
Market Cap£9.53B£9.58B£10.62B£2.79B
Dividend Yield0.89%3.44%120.66%6.15%
P/E Ratio51.9927.8827.51368.29
Price / Sales5.9622.88310.0183,501.30
Price / Cash87.8247.7024.0727.89
Price / Book10.983.694.727.04
Net Income£115.40M£364.48M£610.65M£5.89B
7 Day Performance-2.85%-1.29%-0.58%6.05%
1 Month Performance1.63%-0.45%-2.36%-0.22%
1 Year Performance36.82%8.46%12.50%63.72%

Diploma Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DPLM
Diploma
1.5943 of 5 stars
GBX 7,320
-0.1%
GBX 7,044.29
-3.8%
+36.8%£9.53B£1.65B51.993,500
IGG
IG Group
2.0657 of 5 stars
GBX 1,732
-0.7%
GBX 1,288
-25.6%
+29.6%£5.72B£949.10M16.482,754
DPH
Dechra Pharmaceuticals
N/AN/AN/AN/A£4.40B£761.50MN/A2,457
HWDN
Howden Joinery Group
3.716 of 5 stars
GBX 771.50
-0.1%
GBX 1,003.17
+30.0%
-8.5%£4.24B£2.42B15.7412,000
CTY
City of London
N/AGBX 587.57
+0.6%
N/A+19.9%£3.03B£568.96M5.15N/A

Related Companies and Tools


This page (LON:DPLM) was last updated on 8/3/2026 by MarketBeat.com Staff.
From Our Partners